Importantly, this type of NTRK1 activation is significantly associated with 5-year relapse-free survival in neuroblastoma patients [11], strongly suggesting that TP53-dependent NTRK1 activation is an independent biomarker of good prognosis in neuroblastoma [11]. Here, TP53 is linked to neuroblastoma.